Introduction {#s1}
============

Membrane fusion, the final stage of intracellular vesicular traffic, is tightly regulated so that cargos are delivered to destination compartments in an accurate and timely manner ([@bib4]). The core proteins required for fusion are conserved from the yeast vacuole to the synaptic active zone ([Table 1](#tbl1){ref-type="table"}). These include compartment-specific SNARE and SM (Sec1/Munc18) proteins, the SNARE disassembly ATPase Sec18/NSF (N-ethylmaleimide-sensitive factor), and its essential recruitment adapter Sec17/α-SNAP (soluble NSF attachment protein; [@bib37]; [@bib38]; [@bib75]; [@bib78]; [@bib86]).10.7554/eLife.02272.003Table 1.Nomenclature of general and compartment-specific SNAREs and SNARE cofactors employed in this study, and their equivalents in mammalian synaptic exocytosis**DOI:** [http://dx.doi.org/10.7554/eLife.02272.003](10.7554/eLife.02272.003)YeastMammalGeneralGeneralAAA-family ATPaseSec18NSFSec18 adapterSec17α-SNAPGolgiVacuoleSynaptic exocytosisSM proteinSly1Vps33Munc18-1Qa-SNARESed5Vam3SyntaxinQb-SNAREBos1Vti1SNAP-25 (N-domain)Qc-SNAREBet1Vam7SNAP-25 (C-domain)R-SNARESec22Nyv1Synaptobrevin (VAMP2)[^1]

During docking, SNAREs on apposed vesicle and target membranes oligomerize *in trans*, 'zippering' into an ultrastable coiled-coil bundle. SNARE zippering pulls the membranes into tight apposition, locally deforming and dehydrating the bilayers to initiate fusion and compartmental mixing ([@bib27]; [@bib51]; [@bib76]; [@bib21]). Following fusion, individual SNAREs are entrapped within stable, fusion-inactive *cis-*complexes. To separate the SNAREs and energize them for additional instances of *trans*-complex assembly and membrane fusion, Sec17 binds the *cis*-SNARE complex, in turn recruiting Sec18. Sec18, a hexameric AAA-family ATPase, disassembles the *cis*-SNARE complex and ejects Sec17 ([@bib72]; [@bib47]; [@bib27]; [@bib42]; [@bib26]; [@bib87]; [@bib46]; [@bib13]).

SNAREs alone can fuse membranes in vitro ([@bib84]), but fusion in vivo requires additional cofactors including regulatory small G proteins, compartment-specific tethers, and proteins of the SM family ([@bib36]; [@bib86]; [@bib75]; [@bib89]; [@bib38]). SM proteins are SNARE-interacting ∼600 residue proteins with a highly conserved tertiary fold ([@bib12]; [@bib65]). Four SM subfamilies are essential for fusion within specific subcellular domains: ER and Golgi (Sly1; [@bib9]; [@bib17]); plasma membrane (Sec1/Munc18; [@bib26]; [@bib29]; [@bib34]; [@bib53]; [@bib80]; [@bib85]); endosomes (Vps45; [@bib15]; [@bib60]); and late endolysosomal organelles (Vps33; [@bib2]; [@bib82]). The in vivo SM requirement is so general and so stringent that SMs are now considered, along with SNAREs, to be components of the core fusion machinery ([@bib75]). However, the biochemical mechanisms underlying the in vivo SM requirement are opaque.

Various hypotheses have been proposed to explain the function of SMs in fusion. A major reason for the proliferation of models is that different SMs have divergent SNARE binding modalities ([@bib12]; [@bib65]). However, accruing evidence suggests that SMs share a core ability to bind cognate ternary or quaternary SNARE bundles ([@bib11]; [@bib69]; [@bib10]; [@bib77]; [@bib18]; [@bib41]; [@bib43]). These observations prompted the conjecture that the central, evolutionarily conserved function of SM proteins involves their direct association with assembling pre-fusion *trans-*SNARE complexes ([@bib12]; [@bib65]). Indeed, Sec1 and Munc18-1 accelerate SNARE-mediated liposome fusion by several-fold ([@bib69]; [@bib71]; [@bib63]). This acceleration is contingent on initial reaction conditions, and recent experiments show that Munc18-1 stimulates liposome fusion more efficiently in concert with the specialist exocytosis cofactors Munc13 and synaptotagmin ([@bib44]). Similarly, Vps33, Vps45, and Sly1 accelerate liposome fusion, but with nearly absolute requirements for additional factors including Rab proteins and tethering factors ([@bib30]; [@bib54]; [@bib25]). It remains unclear how SM proteins accelerate SNARE-mediated fusion, and it is unknown whether the kinetic stimulation observed in vitro is sufficient to explain absolute requirements for SMs in vivo.

In a different and not mutually exclusive role, SM proteins might interact with SNARE recycling factors. In vitro, Sec18 and Sec17 can disassemble pre-fusion *trans*-SNARE complexes and can prevent the fusion of intact yeast lysosomal vacuoles or liposomes ([@bib79]; [@bib67]; [@bib50]; [@bib74]). Premature SNARE disassembly was impeded by the Vps-C tethering complex HOPS ([@bib88]). This protective activity of HOPS was hypothesized to reside within its SM subunit Vps33, which is necessary and sufficient for HOPS binding to the vacuole SNARE complex ([@bib43]). Similarly, Munc18-1, acting in concert with Munc13 and synaptotagmin, facilitated SNARE-mediated liposome fusion in the presence of otherwise inhibitory concentrations of NSF and α-SNAP (Sec18 and Sec17; [@bib44]). In the absence of NSF and α-SNAP, Munc18 and Munc13 had little or no effect on the extent of SNARE-mediated liposome fusion when compared to fusion driven solely by SNAREs and synaptotagmin. These findings led to proposals that SMs protect pre-fusion SNARE complexes from premature disassembly while exposing post-fusion complexes and mis-assembled or non-cognate pre-fusion complexes to disassembly by Sec18 ([@bib50]; [@bib73]; [@bib65]). However, central predictions of these models are still untested. Direct protection of a SNARE complex by an SM has not been experimentally demonstrated, and it is unknown whether SM proteins functionally interact (or compete) with the disassembly machinery in living cells.

Using *Saccharomyces cerevisiae* as an experimental platform, we tested the hypothesis that SMs functionally interact not only with SNAREs, but also with Sec17 and Sec18. Through a combination of genetic manipulations in vivo, and in vitro assays of SNARE complex assembly and disassembly, we establish that SM proteins directly impair Sec18-mediated SNARE disassembly. In the course of these studies we discovered that Sec17 directly promotes selective loading of at least two different SM proteins onto cognate SNARE complexes. Moreover, an extraordinarily steep temperature dependence limits SM loading onto SNARE complexes, implying that SM-SNARE complex formation entails significant conformational transitions. The thermal dependence of SM loading may partially explain why SNARE--Sec17--SM complexes eluded detection in previous studies.

Results {#s2}
=======

Wild-type SM proteins are required to resist Sec17 and Sec18 overproduction {#s2-1}
---------------------------------------------------------------------------

In vitro reconstitution experiments led to models in which SM proteins, in conjunction with additional SNARE cofactors, functionally oppose Sec17 and Sec18 activity ([@bib50]; [@bib74]; [@bib88]; [@bib44]). To probe for antagonism between SMs and SNARE disassembly factors in vivo, we turned to the late endolysosomal SM Vps33. We recently characterized a hypomorphic *VPS33* allele, *vps33*^car^. Vps33^car^ (G297V) is an analog of the *Drosophila* Vps33a (G249V) mutant, encoded by *carnation*^*1*^, probably the first SM allele ever isolated ([@bib56]; [@bib70]). Null mutant *vps33*Δ cells, or *vps33*^*R281A*^ functional nulls ([@bib43]), have severe trafficking defects, lack identifiable vacuolar lysosomes (*vps* class C morphology; [@bib64]), and are inviable at 37°C. In contrast, *vps33*^car^ mutants retain partial function, with milder defects in vacuolar cargo sorting, moderate (Class B) vacuole fragmentation, and slow growth at 37°C ([@bib43]). When Sec17 and Sec18 were overproduced in wild-type *VPS33* cells, growth was normal at either standard temperature (30°C) or at 37°C ([Figure 1A](#fig1){ref-type="fig"}). In marked contrast, Sec17 and Sec18 overproduction in mutant *vps33*^car^ cells caused severe growth defects at 37°C ([Figure 1A](#fig1){ref-type="fig"}). As an additional control we overproduced Sec17 and Sec18 in another Class B *vps* mutant, *vps41Δ*. Vps41 is, with Vps33, a subunit of the HOPS tethering complex. There was little or no growth defect when Sec17 and Sec18 were overproduced in *vps41*Δ cells ([Figure 1A](#fig1){ref-type="fig"}).10.7554/eLife.02272.004Figure 1.Partial Vps33 deficiency sensitizes cells to overproduction of SNARE disassembly proteins.(**A**) Limiting dilution growth assay on synthetic media agar plates incubated at 37°C. (**B**) Growth curves in selective, synthetic liquid media (YNB lacking uracil and containing 0.05% casamino acids and 2% dextrose, with or without 1 mM ZnCl~2~). Data points represent the means of n = 4 samples. (**C**) LUCID analysis of luminal sorting efficiency of the vacuole cargo Sna3-fLuc. Note that *vps33*^*car*^ is a hypomorphic allele with partial loss-of-function, while *vps33* ^*R281A*^ is a functional null with total loss of function. Box plots summarize n = 5 biological replicates, except for *vps33* ^*R281A*^ (n = 4). \*\*p\<0.01 (one-way ANOVA). fLuc, firefly luciferase. *2µ*, high copy plasmid vector.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.004](10.7554/eLife.02272.004)

The late endosome and vacuolar lysosome are required for metal tolerance in *S. cerevisiae*. For this reason, growth in the presence of added Zn^2+^ is a classical indicator of intact endolysosomal function. Wild-type *VPS33* cells grew at equal rates with or without 1 mM Zn^2+^. Overproduction of Sec17, Sec18, or both together had almost no effect on growth of *VPS33* cells, with or without added Zn^2+^ ([Figure 1B](#fig1){ref-type="fig"}, top panel). *vps33*^car^ mutants grew almost as well as *VPS33* cells, but when Sec17, or Sec17 and Sec18 were overproduced together, the *vps33*^car^ mutants grew slowly ([Figure 1B](#fig1){ref-type="fig"}, middle panel), a defect markedly enhanced by 1 mM Zn^2+^ ([Figure 1B](#fig1){ref-type="fig"}, bottom panel). Thus, Sec17 or Sec17 and Sec18 overproduction strongly exacerbate defects in endolysosomal function, even when Vps33 function is only partially impaired. To test for synthetic trafficking defects we employed LUCID, a quantitative assay of traffic from the Golgi to the late endosome. LUCID uses a chimeric reporter, the cargo protein Sna3 fused to firefly luciferase (fLuc). Sna3-fLuc accumulates when endolysosomal traffic or cargo sorting into multivesicular bodies is impaired ([@bib52]; [@bib57]). *Renilla* luciferase is co-expressed to control for expression and nonspecific protein turnover. Sec17 overproduction in *vps33*^car^ cells, but not in wild-type cells, significantly impaired Sna3-fLuc sorting ([Figure 1C](#fig1){ref-type="fig"}). Together, the data show that full Vps33 function is required to withstand either Sec17 or Sec17 and Sec18 overproduction.

To test for functional interactions between Sec17 and Sec18 and another SM, we studied a conditional mutant of Sly1, the Golgi SM. *sly1*^ts^ mutant cells grow almost as well as wild-type cells at permissive temperature (26°C) but cannot grow at elevated temperatures ([@bib9]). Wild-type *SLY1* cells grew normally when Sec17 and Sec18 were overproduced, alone or together ([Figure 2](#fig2){ref-type="fig"}). In contrast, overproduction of Sec17, or Sec17 and Sec18 together, profoundly impaired the growth of *sly1*^ts^ mutants, even at permissive temperatures (24--26°C; [Figure 2](#fig2){ref-type="fig"}). In independent work, *sly1*^ts^ *sec18-1* double mutants were inviable ([@bib40]). We conclude that full, wild-type Sly1 and Vps33 function is required to buffer cells against perturbations of the SNARE disassembly machinery.10.7554/eLife.02272.005Figure 2.Partial Sly1 deficiency sensitizes cells to overproduction of SNARE disassembly proteins.(**A**) Limiting dilution growth assay on plasmid-selective, synthetic media agar plates at 24°, 30° and 37°C. (**B**) Growth curves of yeast in selective, synthetic liquid media at 26°C. Data points each represent the mean of nine replicate samples. *2µ*, high copy plasmid vector.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.005](10.7554/eLife.02272.005)

SM proteins reduce the rate of SNARE disassembly by Sec18 {#s2-2}
---------------------------------------------------------

To test the hypothesis that SM proteins directly regulate the activities of Sec17 and Sec18, we established an in vitro assay of SNARE complex disassembly ([Figure 3A](#fig3){ref-type="fig"}). Vacuole and Golgi SM proteins, cognate SNAREs, and Sec17 and Sec18 were individually purified ([Table 1](#tbl1){ref-type="table"}; [Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Golgi or vacuole SNARE complexes ([Table 1](#tbl1){ref-type="table"}) were then assembled on immobilized Qa-SNAREs. We emphasize that the SNARE constructs, assembled on affinity supports to probe protein--protein interactions, encoded only cytoplasmic domains, not transmembrane segments. Consequently, the complexes formed from these proteins cannot be described using the membrane-dependent topological terms *cis-* and *trans*-. Using conditions optimized for Vps33--SNARE complex binding ([@bib43]), SNARE complexes were incubated with Sec17, with or without the cognate SM (Vps33 or Sly1). Sec18 was then added to initiate disassembly. In the absence of SMs, Sec18 rapidly and completely disassembled the SNARE complexes ([Figure 3B,C](#fig3){ref-type="fig"}, lanes 1--5). Disassembly required ATP and was blocked when Mg^2+^ was sequestered by EDTA ([Figure 3B,C](#fig3){ref-type="fig"}, compare lanes 5 and 6). Pre-incubation with SMs (Sly1 or Vps33) delayed, but did not prevent, SNARE disassembly ([Figure 3B,C](#fig3){ref-type="fig"}, lanes 7--11). The effect of Sly1 was quantified: pre-incubation with the Sly1 decreased the rate of disassembly by 63 ± 9% ([Figure 3---figure supplement 2](#fig3s2){ref-type="fig"}). The Sed5 (Qa-SNARE) used for the experiments shown in [Figure 3B,D](#fig3){ref-type="fig"} contained only the SNARE domain, and not the H~abc~ or N-peptide domains. However, Sly1 also protected Golgi SNARE complexes assembled on Sed5 full cytoplasmic domain rather than Sed5 SNARE domain ([Figure 3---figure supplement 3](#fig3s3){ref-type="fig"}). In control reactions the ability of the Sly1 and Vps33 preparations to impede SNARE disassembly was heat labile ([Figure 3D,E](#fig3){ref-type="fig"}, compare lanes 3 and 5). Omitting the pre-incubation step reduced both SM binding and SNARE complex protection ([Figure 3---figure supplement 4](#fig3s4){ref-type="fig"}).10.7554/eLife.02272.006Figure 3.SM proteins oppose Sec18-mediated SNARE disassembly.(**A**) Schematic of SNARE disassembly assay. SNARE complexes assembled onto immobilized Qa-SNAREs (Vam3 cytoplasmic domain or Sed5 SNARE domain) were pre-incubated in the presence of Sec17, with or without added SM (Vps33 or Sly1). Sec18 was added to initiate disassembly. The remaining resin-bound material was washed, collected, and analyzed by SDS-PAGE at indicated times. (**A** and **B**) Sec17 (20 μM) and Sly1 (10 μM) or Vps33 (2.5 μM) were pre-incubated with SNARE complexes (500 nM) at 30°C for 60 min in Disassembly Buffer. Sec18 (300 nM) was then added. Under these conditions each Sec18 hexamer catalyzed disassembly of \>10 SNARE complexes. In negative controls (lanes 6 and 12), Mg^2+^ was chelated with EDTA prior to Sec18 addition. (**D** and **E**) SNARE complex disassembly was assayed as in **B** and **C**, but with variable SM protein concentrations as indicated. In ΔSly1 or ΔVps33 lanes, the SM solutions were heated in a boiling water bath for 10 min, plunged into ice-water, and then clarified at 20 k × g to rule out effects of potential heat-stable contaminants in the preparations.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.006](10.7554/eLife.02272.006)10.7554/eLife.02272.007Figure 3---figure supplement 1.Purified Proteins.Purified components used in SNARE complex disassembly and binding assays were separated by SDS-PAGE and stained with Coomassie blue.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.007](10.7554/eLife.02272.007)10.7554/eLife.02272.008Figure 3---figure supplement 2.Quantification of SNARE complex protection by Sly1.Immobilized SNARE complexes (125 pmol in a 250 µl reaction) were pre-incubated for 1 hr at 30°C with saturating Sec17, and with or without Sly1. As in [Figure 3](#fig3){ref-type="fig"}, disassembly was initiated by adding Sec18 (12.5 pmol of hexamer). Resin-bound material was washed, collected, and bound proteins were separated by SDS-PAGE and visualized with SYPRO-Ruby. Standard curves of purified proteins were used to determine the amount complex remaining at the indicated times. In the presence of Sly1 the disassembly rate was 0.83 ± 0.04 complexes per Sec18 hexamer per min. In the absence of Sly1 the rate was 1.35 ± 0.01 complexes per Sec18 hexamer per min. Both calculations assume a Sec18 specific activity of 50% and ∼20 turnovers per Sec18 hexamer. Comparable rates of neuronal SNARE disassembly by NSF and α-SNAP (∼1 complex per Sec18 hexamer per min, in 100 mM KCl) were recently reported by [@bib13] ([Figure 2G](#fig2){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.02272.008](10.7554/eLife.02272.008)10.7554/eLife.02272.009Figure 3---figure supplement 3.Sly1 protection of SNARE complexes assembled on Sed5 containing Habc domain and N-peptide.Golgi SNARE complex (500 nM) was assembled on immobilized Sed5 SNARE domain (GST-Sed5FL) containing a Habc domain and N-peptide. SNARE complexes were incubated with Sec17 (20 μM), Sly1 (10 μM), or both for 60 min at 30°C in SM Assay Buffer supplemented with 1 mM ATP and 2 mM MgCl2. 300 nM Sec18 was then added for the indicated period of time, unbound material was washed out, and the bound proteins were analyzed by SDS-PAGE and Coomassie blue staining.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.009](10.7554/eLife.02272.009)10.7554/eLife.02272.010Figure 3---figure supplement 4.Pre-incubation of Sly1 with SNARE complexes increases the fraction of SNARE complex resistant to Sec18-mediated disassembly.SNARE complex disassembly was performed as described in [Figure 3](#fig3){ref-type="fig"}, with the exception that Sly1 was in the reaction for lane 4 was added simultaneously with Sec18. In lane 5, Sly1 was pre-incubated for the standard 1 hr prior to addition of Sec18. Dashed vertical lines indicate samples from a single experiment, run on parallel gels. Note that GST-Sed5 serves as a loading control.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.010](10.7554/eLife.02272.010)

Substantial amounts of Vps33 and Sly1 remained bound to immobilized Qa-SNAREs even after complete SNARE complex disassembly ([Figure 3B,C](#fig3){ref-type="fig"}, lanes 11). This raised the possibility that the SMs could capture Qa-SNAREs in an assembly-active state. Thus, it was necessary to test whether bound SM proteins reduce the rate of SNARE complex disassembly or, alternatively, accelerate SNARE complex re-assembly. To evaluate these alternatives, SNARE complexes were completely disassembled using Sec17, Sec18, and ATP. Sec18 activity was then quenched with EDTA and the reactions were incubated for an additional 30 min ([Figure 4A](#fig4){ref-type="fig"}). At the low concentrations of free SNAREs liberated by disassembly, no re-assembly of SNARE complexes was detected within 30 min in either the absence or presence of SM ([Figure 4B,C](#fig4){ref-type="fig"}, compare lanes 1 and 3, and lanes 2 and 4). We next tested the competence of the Qa-SNARE for de novo assembly following Sec18-mediated disassembly. After complete disassembly, additional Qb, Qc, and R-SNAREs were added along with the EDTA quench ([Figure 4B,C](#fig4){ref-type="fig"}, compare lanes 5 and 6). Under these conditions re-assembly occurred, but the rates of re-assembly were not increased by either Vps33 or Sly1, in accord with previous reports that these SMs do not accelerate SNARE assembly in solution ([@bib39]; [@bib58]; [@bib31]).10.7554/eLife.02272.011Figure 4.Vps33 and Sly1 do not accelerate SNARE complex re-assembly in solution.(**A**) Cartoon schematic of the re-assembly assay. (**B** and **C**) SNARE complexes (500 nM) were assembled as in [Figure 3](#fig3){ref-type="fig"}. Following pre-incubation of SNARE complexes with 20 μM Sec17 and SM (10 μM Sly1 or 2.5 μM Vps33, as indicated), SNARE complexes were completely disassembled for 30 min by Sec18. Disassembly was terminated with EDTA, and SNARE complex re-assembly was assayed after a further 30 min at 30°C. As indicated, some re-assembly reactions (lanes 5 and 6) were supplemented with soluble SNAREs (Qb, Qc, and R; ∼3 μM each), which were added along with the EDTA quench.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.011](10.7554/eLife.02272.011)

We conclude that Vps33 and Sly1 kinetically impair, but do not prevent, Sec18-mediated SNARE disassembly. Because Vps33 is both necessary and sufficient for HOPS binding to SNARE core bundles ([@bib43]), Vps33 likely accounts for the ability of HOPS to shield *trans*-SNARE complexes from premature disassembly ([@bib88]). Because Vps33 and Sly1 exhibit similar activities, protection of *trans*-SNARE complexes from Sec18/NSF may be a more general feature of SM biochemistry. Liposome fusion experiments with SMs from the other two SM subfamilies, Vps45 and Munc18-1, are also consistent with this interpretation ([@bib54]; [@bib44]).

Sec17 promotes Vps33 binding to the vacuole SNARE complex {#s2-3}
---------------------------------------------------------

Up to three copies of Sec17/α-SNAP bind per SNARE complex bundle ([@bib27]; [@bib23]; [@bib46]; [@bib81]), and α-SNAP can competitively displace the presynaptic Ca^2+^ sensor synaptotagmin from neuronal SNARE complexes ([@bib72]). Thus, it was surprising to observe both Sec17 and Vps33 bound to SNARE complexes in our disassembly assays (e.g., [Figure 3C](#fig3){ref-type="fig"}, lanes 7 and 12). Similarly, both Sec17 and Sly1 associated with Golgi SNARE complex, even though the Sed5 (Qa-SNARE) construct used lacked the N-peptide, a high-affinity recruitment site for the Sly1 (e.g., [Figure 3B](#fig3){ref-type="fig"}, lanes 7 and 12). To test whether Sec17 and SMs compete for binding, immobilized vacuolar SNARE complexes were assayed for binding of Vps33, Sec17, or both. As we previously reported ([@bib43]), Vps33 binds the vacuole SNARE complex with low µM affinity ([Figure 5A](#fig5){ref-type="fig"}, lane 2). But rather than competing, Sec17 addition strongly stimulated Vps33 binding to the SNARE complex ([Figure 5A](#fig5){ref-type="fig"}, lane 4). Importantly, the stoichiometry of Sec17 binding was unaltered when Vps33 was also bound ([Figure 5A](#fig5){ref-type="fig"}, compare lanes 3 and 4).10.7554/eLife.02272.012Figure 5.Sec17 promotes Vps33 binding to vacuole SNARE complex.(**A**) SNARE complex (500 nM) was assembled on Vam3-GST. Sec17 (20 μM), Vps33 (2.5 μM), or both were incubated with the SNARE complex for 1 hr at 30°C in SM Assay Buffer. Unbound material was washed out, then bound material was separated by SDS-PAGE and visualized with Coomassie blue. (**B**) The dose--response for Sec17 stimulation of Vps33 binding to SNARE complexes was assayed as in **A**, but Sec17 concentration was varied (0.5--20 μM) while Vps33 was held constant (2.5 μM). (**C**) Vps33 binding to SNARE complex with or without Sec17 was assayed as in **A** and **B**, except that Vps33 concentration was varied and protein bands were stained and quantified using SYPRO Ruby. The fractional saturation of total Vps33--SNARE complex binding was plotted vs free (total minus bound) Vps33. Fits of a one-site binding model yielded Kd~obs~ = 300 ± 10 nM for Vps33 binding to the SNARE complex in the presence of Sec17, and Kd~obs~ = 1.6 ± 0.10 µM without Sec17. Two-site or cooperative binding models did not substantially improve the fits. (**D**) To estimate the stoichiometry of SNARE--Sec17--Vps33 binding, complexes were assembled under saturation binding conditions, separated by SDS-PAGE, and analyzed using SYPRO Ruby stain. The band intensities were quantified using standard curves generated with individual purified proteins. (**E**) Vps33 binding is stimulated by SNARE-associated Sec17. Complexes were assayed in lanes 1 and 2 as in **A**. In lane 3 (Sec17 pre-bound), Sec17 was bound to SNARE complexes for 60 min at 30°C. Unbound Sec17 was washed out and 2.5 μM Vps33 was then added for an additional 60 min at 30°C. In lane 4, 20 µM BSA was substituted for Sec17. (**F**) Cooperativity of assembly. GST-Vps33 (500 nM) was immobilized and incubated with 20 μM Sec17, soluble SNARE complex, or both. Bound material was separated by SDS-PAGE and stained with Coomassie blue, or analyzed by immunoblot.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.012](10.7554/eLife.02272.012)

Sec17 stimulation of Vps33 binding to the SNARE complex depended on the Sec17 concentration and tracked with Sec17 occupancy on the complex ([Figure 5B](#fig5){ref-type="fig"}). Vps33-SNARE complex binding was saturable ([Figure 5C](#fig5){ref-type="fig"}), and Sec17 increased the apparent affinity of Vps33 for SNARE complex by more than 5-fold (from K~D(obs)~ = 1.60 ± 0.10 μM to 0.30 ± 0.01 μM). As these are non-equilibrium measurements, we caution that they may systematically underestimate absolute SNARE-SM affinities. Under saturation binding conditions, Sec17--Vps33--SNARE complexes assembled in apparent 1:3:1 stoichiometry ([Figure 5D](#fig5){ref-type="fig"}).

The above results argue that SNARE-bound Sec17 stimulates Vps33 binding. To rule out an alternative possibility, that free Sec17 in solution enhances Vps33 binding activity, Sec17 was bound to SNARE complexes, and unbound Sec17 was washed out before Vps33 was added ([Figure 5E](#fig5){ref-type="fig"}). Vps33 bound to SNARE complex equally well in the presence of free-plus-bound Sec17 ([Figure 5E](#fig5){ref-type="fig"}, lane 2) or to SNARE--Sec17 complex from which excess unbound Sec17 had been removed ([Figure 5E](#fig5){ref-type="fig"}, lane 3). Thus, Vps33 binding is stimulated by Sec17 on the SNARE complex, not by Sec17 in solution. In a further control, addition of bovine serum albumin (BSA) in place of Sec17 had no effect on Vps33 binding to SNARE complex ([Figure 5E](#fig5){ref-type="fig"}, lane 4). To test whether Vps33 binds Sec17 directly, GST-Vps33 was immobilized and assayed for binding of soluble SNARE complex, Sec17, or both ([Figure 5F](#fig5){ref-type="fig"}). SNARE complex and Sec17 bound efficiently to immobilized Vps33 only when both were present ([Figure 5E](#fig5){ref-type="fig"}, compare lane 4 to lanes 2 and 3). SNARE complexes and Sec17 therefore bind Vps33 through a cooperative mechanism involving all three components.

Sec17 promotes Sly1 binding to the Golgi SNARE complex {#s2-4}
------------------------------------------------------

A co-complex between SNAREs, Sec17, and an SM is unprecedented. Thus, it was essential to test whether similar results might be obtained with a divergent SM protein and its cognate SNAREs. We again turned to Sly1, the Golgi SM. Sly1 was previously shown to avidly bind the terminal N-peptide of the Qa-SNARE Sed5. However, N-peptide binding is dispensable for Sly1 function in vivo ([@bib6]; [@bib58], [@bib59]). To examine N-peptide-independent Sly1 binding, Golgi SNARE complex was assembled on an immobilized, truncated Sed5 SNARE domain that lacks both the N-peptide and H~abc~ domains (GST-Sed5~SNARE\ domain~). As in previous work ([@bib59]) little or no Sly1 bound to the Golgi SNARE bundle. In the presence of Sec17, however, Sly1 binding was dramatically stimulated ([Figure 6A](#fig6){ref-type="fig"}, compare lanes 2 and 4).10.7554/eLife.02272.013Figure 6.Sec17 promotes Sly1 binding to Golgi SNARE complex.(**A**) Golgi SNARE complex (500 nM) was assembled on immobilized Sed5 SNARE domain (GST-Sed5~SNARE\ domain~) lacking the N-peptide and H~abc~ segments. SNARE complexes were incubated with Sec17 (20 μM), Sly1 (10 μM), or both for 60 min at 30°C. Unbound proteins were washed out, and bound proteins were separated by SDS-PAGE and stained with Coomassie blue. (**B**) The dose--response for Sec17 stimulation of Sly1 binding to SNARE complexes was assayed as in **A**, but Sec17 concentration was varied (2.5--20 μM) while Sly1 was held constant (10 μM). In lanes 7 and 8, the full cytoplasmic domain of Sed5 (Sed5~FL~, including the H~abc~ and N-peptide segments; 500 nM) was immobilized to test for direct binding of Sec17 to Sed5 and Sly1 in the absence of assembled SNARE complex. (**C**) Sly1 binding to SNARE complex with or without Sec17 was assayed as in **A** and **B**, except that Sly1 concentration was varied and protein bands were stained and quantified using SYPRO Ruby. The fractional saturation of total Sly1-SNARE complex binding was plotted vs free (total minus bound) Sly1. Fits of a one-site binding model yielded with an apparent Kd~obs~ = 1.0 ± 0.1 µM for Sly1 binding to the SNARE complex in the presence of Sec17. It was not possible to fit the no-Sec17 condition. Two-site or cooperative binding models did not substantially improve the fits. (**D**) Stoichiometry of SNARE-Sec17-Sly1 complexes assembled under saturation conditions was estimated using standard curves of purified proteins of known concentrations. (**E**) Sly1 binding is stimulated by SNARE-associated Sec17. Binding was assayed in lanes 1 and 2 as in **A**. In lane 3, Sec17 was pre-bound to SNARE complexes for 60 min at 30°C. Unbound Sec17 was then washed out and Sly1 (10 μM) was added for an additional 60 min at 30°C. In lane, 4 BSA (20 µM) was substituted for Sec17. (**F**) Cooperativity of assembly. GST-Sly1 (500 nM) was immobilized and incubated with 20 μM Sec17, SNARE complex, or both. Bound material was separated by SDS-PAGE and stained with Coomassie blue or analyzed by immunoblot.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.013](10.7554/eLife.02272.013)

As with Vps33, Sly1 binding to SNARE complex depended on the Sec17 concentration and tracked with Sec17 occupancy on the complex ([Figure 6B](#fig6){ref-type="fig"}, lanes 1-6). Sec17 did not associate with, or impede formation of, binary complexes between Sly1 and the N-peptide of full-length Sed5 ([Figure 6B](#fig6){ref-type="fig"}, lanes 7 and 8). Thus, Sec17 stimulates Sly1--SNARE complex association, but Sec17 does not efficiently bind Sly1 or Sed5 in the absence of an assembled SNARE complex. Sly1 bound to the Sec17--SNARE complex saturably and with moderate affinity ([Figure 6C](#fig6){ref-type="fig"}; K~D(obs)~ = 1.0 ± 0.1 µM). We emphasize that this binding was measured under conditions where Sly1--Sed5 N-peptide binding cannot occur, as the Sed5 construct lacks the N-peptide and H~abc~ domains. In the absence of Sec17, little or no Sly1 bound the SNARE bundle at concentrations up to 15 µM. Under saturation conditions the SNARE complex, Sec17, and Sly1 assembled in apparent 1:3:1 stoichiometry, consistent with the results for Vps33 ([Figures 5D and 6D](#fig5 fig6){ref-type="fig"}).

As with Vps33, Sly1 binding was promoted by SNARE-bound Sec17 rather than Sec17 in solution ([Figure 6E](#fig6){ref-type="fig"}). The Sec17 concentration required to saturate Golgi SNARE complex was about four-fold greater than for vacuole SNARE complex (compare the Sec17 curves in [Figures 5B and 6B](#fig5 fig6){ref-type="fig"}). Consistent with this observation, Golgi SNARE complex pre-bound to Sec17 and then washed retained less Sec17, and commensurately less Sly1, versus pulldowns in which Sec17 was in excess ([Figure 6E](#fig6){ref-type="fig"}, compare lanes 2 and 3). No increase in Sly1 binding to Golgi SNARE complexes was observed when BSA was added instead of Sec17 ([Figure 6E](#fig6){ref-type="fig"}, lane 4). Sly1, like Vps33, binds SNARE--Sec17 complexes through a cooperative mechanism. GST-tagged Sly1 was immobilized and assayed for binding of soluble SNARE complex, Sec17, or both ([Figure 6F](#fig6){ref-type="fig"}). SNARE complex was retained by GST-Sly1 only in the presence of Sec17, and Sec17 was retained most efficiently on GST-Sly1 when SNARE complexes were present. There may be some affinity between GST-Sly1 and Sec17 in the absence of SNARE complex under these conditions. However, Sec17 did not detectably interact with Sly1 when Sly1 was tethered to the GST-Sed5 N-peptide ([Figure 6B](#fig6){ref-type="fig"}, lanes 7 and 8). We conclude that Sec17 promotes Sly1 and Vps33 loading onto SNARE complexes through a cooperative mechanism. The resulting assemblies contain three Sec17 molecules and one SM per quaternary SNARE bundle.

Sec17 promotes selective SM loading onto cognate SNARE complexes {#s2-5}
----------------------------------------------------------------

Sec17 and its mammalian homolog α-SNAP are capable of engaging all SNARE complexes. In contrast, the SM proteins operate at specific organelles and preferentially recognize cognate, pathway-specific SNAREs and SNARE complexes ([@bib12]; [@bib65]). Sec17 can bind SNARE complexes as a trimer, raising the possibility that Vps33 and Sly1 recognize composite features of the Sec17 multimer surface but do not touch the underlying SNAREs. If this model is correct, Sec17-stimulated SM binding to SNARE complexes should exhibit no selectivity for the underlying SNARE bundle. In an alternative model, SM proteins touch and recognize cognate SNARE complexes during Sec17-stimulated binding. This model predicts that Sec17-stimulated SM binding should be SNARE-selective and compartment-specific.

To evaluate these models, Golgi and vacuole SNARE complexes were assembled and assayed for Vps33 and Sly1 binding in the absence or presence of Sec17 ([Figure 7](#fig7){ref-type="fig"}). In the presence of Sec17, Vps33 preferentially bound to vacuole SNARE complexes ([Figure 7A](#fig7){ref-type="fig"}, lanes 3 and 3\'). In the reciprocal experiment, Sec17 promoted selective Sly1 binding to cognate Golgi SNARE complexes ([Figure 7B](#fig7){ref-type="fig"}, lanes 3 and 3\'). Sec17 therefore promotes selective recognition of cognate SNARE complexes by both Vps33 and Sly1. These findings further underscore the cooperativity of Sec17, SM, and SNARE complex co-assembly ([Figures 5 and 6](#fig5 fig6){ref-type="fig"}) and indicate that even when a Sec17 trimer is bound, Vps33 and Sly1 recognize organelle-specific determinants on the underlying SNARE complex.10.7554/eLife.02272.014Figure 7.SM proteins touch and recognize cognate SNARE-Sec17 complexes.Golgi and vacuole SNARE complexes (500 nM) were assembled on affinity supports and assayed for binding in the absence or presence of Sec17 (20 μM). (**A**) Assay of Vps33 (2.5 μM) binding. (**B)** Assay of Sly1 (10 µM) binding. Golgi complexes were assembled on Sed5 SNARE domain lacking the N-peptide and H~abc~ segments. Binding reactions were incubated 2 hr at 30°C, unbound material was washed out, and the bound proteins were analyzed by SDS-PAGE and Coomassie blue staining.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.014](10.7554/eLife.02272.014)

SM binding to SNARE complexes is strongly temperature-dependent {#s2-6}
---------------------------------------------------------------

Unexpectedly, Sly1 binding to the SNARE-Sec17 complex increased markedly from 4° to 30°C, the physiological growth temperature ([Figure 8A](#fig8){ref-type="fig"}, compare lanes 4, 7, and 10). In assays performed across a range of temperatures ([Figure 8B](#fig8){ref-type="fig"}), Sly1 loading onto SNARE--Sec17 complex decreased by an order of magnitude as temperature dropped from 26.5°C to 20°C. In control experiments there was no comparable temperature dependence ([Figure 8B](#fig8){ref-type="fig"}: binding of Sly1 to Sed5 N-peptide, and binding of Sec17 to SNARE complex). Below, we show that thermal stimulation of Sly1--SNARE complex binding is dominated by changes in association rather than dissociation kinetics. Most biochemical processes have a thermal coefficient Q~10~ of 2--4 (change in activity over 10°C temperature gradient; see Hille, 1991). Sly1 binding to the Sec17-SNARE complex has an extrapolated Q~10~ of ∼30, indicating that the Sly1 binding mechanism entails traversal of a large thermodynamic barrier.10.7554/eLife.02272.015Figure 8.Thermal dependence of SM-SNARE complex association.(**A**) Golgi SNARE complexes were assembled on immobilized Sed5 SNARE domain (lacking the Sed5 N-peptide), then assayed for Sly1 (12 µM) binding in the absence and presence of Sec17 (12 µM). The binding reactions were incubated for 60 min at 4°, 24° or 30°C. (**B**) Sly1 binding to Golgi SNARE complexes (S.C.) was evaluated across a range of temperatures. Note that reciprocal temperature is plotted in units of 1/K, with warmer temperatures on the left side of the plot. Immobilized SNARE complexes (500 nM) were assayed for binding of sub-saturating amounts of Sly1 (8 µM, in the presence of 20 µM Sec17), or for binding of Sec17 alone (7 µM). In an additional control, Sly1 (6 µM) was assayed for binding to the N-peptide of Sed5 (FL; full-length cytoplasmic domain; 500 nM). Bound material was separated by SDS-PAGE, visualized with SYPRO Ruby, and quantified using standard curves of purified proteins of known concentrations. (**C**) The thermal dependence of Vps33--SNARE association was assayed as in **A**, except that Vps33 was present at 1 µM and Sec17 was present at 2 µM. (**D**) Vps33 binding to SNARE complexes was evaluated across a range of temperatures, similar to **B**. As indicated, Vps33 was present at 1.5 µM and Sec17 was present at 20 µM. (**E**) The kinetics of Sly1 binding at 30°C to Sec17--SNARE complex were analyzed and quantified using conditions and protein concentrations as in panel **B**. (**F**) Sly1 association kinetics are controlled by temperature. Immobilized Golgi SNARE complex (500 nM) was incubated with Sly1 (10 µM) and Sec17 (20 µM) at the indicated temperatures for the indicated times. Bound proteins were separated by SDS-PAGE and stained with Coomassie blue.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.015](10.7554/eLife.02272.015)10.7554/eLife.02272.016Figure 8---figure supplement 1.Stability of Sly1-Sec17-SNARE complexes at 4° and 30°C.Golgi SNARE complex (500 nM) was assembled on immobilized Sed5 SNARE domain (GST-Sed5) lacking the N-peptide and Habc segments. SNARE complexes were incubated with Sec17 (20 μM), Sly1 (10 μM), or both, and incubated for 60 min at 30°C. Unbound protein was washed out and resins were incubated in SM Assay Buffer at either 4° or 30°C for a further 60 min. Resins were washed again at the post-wash incubation temperature (either 4° or 30°C), and the bound proteins were analyzed by SDS-PAGE and Coomassie blue staining.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.016](10.7554/eLife.02272.016)10.7554/eLife.02272.017Figure 8---figure supplement 2.Pre-incubation at 30°C does not trigger conversion of Sly1 into a persistently activated state.(**A**) Golgi SNARE complex (500 nM) was assembled on immobilized Sed5 SNARE domain (GST-Sed5) lacking the N-peptide and H~abc~ segments. SNARE complexes were then pre-incubated with Sec17 (20 μM) at room temperature for 60 min prior to addition of Sly1 (10 μM). Sly1 was pre-incubated for 60 min either at room temperature (conditions 1 and 2) or 30 C (conditions 3 and 4). In condition 3, Sly1 pre-incubation for 60 min at 30 C is followed by binding at room temperature (RT). Condition 1 shows baseline binding when Sly1 has only been incubated at RT, while condition 4 shows binding of Sly1 at 30 C (standard experimental condition). To control for the addition of 30°C in condition 4, condition 2 shows binding of Sly1 when the SM has been pre-incubated at RT and an equivalent volume of buffer, added at timepoint zero, was pre-incubated at 30°C.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.017](10.7554/eLife.02272.017)

As with Sly1, Vps33 binding increased with temperature ([Figure 8C](#fig8){ref-type="fig"}, compare lanes 4, 7, and 10, and [Figure 8D](#fig8){ref-type="fig"}, blue triangles). In contrast, Sec17 efficiently bound the vacuole SNARE complex at 4°C. Because Vps33 has moderate affinity for vacuole SNARE complex ([Figure 5C](#fig5){ref-type="fig"}; [@bib43]), it was also possible to assess the temperature sensitivity of SNARE complex--Vps33 binding without Sec17. Although Sec17 stimulated Vps33 binding ([Figure 8D](#fig8){ref-type="fig"}, blue triangles), Vps33 bound the SNARE complex most efficiently at elevated (physiological) temperatures even when no Sec17 was present ([Figure 8D](#fig8){ref-type="fig"}, red circles). Thus, elevated temperature directly enhances Vps33 association with its SNARE complex.

To evaluate whether SM binding efficiency is limited by on- or off-rates, SNARE--Sec17--Sly1 co-complexes were formed at 30°C for 60 min, washed in either 30°C buffer or 4°C buffer, and incubated an additional 60 min at the same temperature as the prior wash. There was little Sly1 dissociation at 4°C and slightly more at 30°C ([Figure 8---figure supplement 1](#fig8s1){ref-type="fig"}), indicating that elevated temperature promotes productive SM--SNARE association rather than stabilizing extant SM--SNARE complexes. At 90% saturating levels, Sly1 bound the Sec17--SNARE complex with a half-time of ∼20 min. Under similar conditions, Sly1 binding to the Sed5 N-peptide and Sec17 binding to Golgi SNARE complexes were both complete within 1 min ([Figure 8E](#fig8){ref-type="fig"}). When Sly1 was loaded onto SNARE--Sec17 complexes at 24° instead of 30°C, the time required to reach steady-state binding increased from 1 to 4 hr ([Figure 8F](#fig8){ref-type="fig"}). These observations indicate that the temperature dependence of SM binding is due to rate-limiting steps in SM--SNARE association rather than dissociation. A possible interpretation is that Vps33 and Sly1 slowly interconvert between ground states unable to bind SNARE complexes and activated, binding-competent, states. SNARE-bound Sec17---and perhaps other docking factors---would then elicit or stabilize activated SM conformations to accelerate SM loading onto cognate SNARE complexes. Because pre-incubation of Sly1 at 30°C did not accelerate subsequent Sly1 binding to Sec17-SNARE complexes ([Figure 8---figure supplement 2](#fig8s2){ref-type="fig"}), we suggest that elevated temperature increases the frequency of interconversion between the putative ground and binding-active conformations, rather than by stabilizing an activated conformation.

Discussion {#s3}
==========

Crosstalk between SNARE assembly and disassembly factors {#s3-1}
--------------------------------------------------------

Pioneering biochemical and genetic studies led to the idea that parallel N-to-C zippering of SNARE complexes *in trans* pulls membranes together to initiate fusion ([@bib27]; [@bib51]; [@bib62]; [@bib76]). SNAREs are sufficient to drive basal fusion of liposomes ([Figure 9A](#fig9){ref-type="fig"}, reaction i) and impose a layer of compartmental specificity ([@bib84]; [@bib49]). In these minimal systems, purified SM proteins accelerate fusion (reaction ii; [@bib69]; [@bib71]; [@bib25]). However, the significant basal activities of SNAREs and the relatively modest rate enhancements conferred by SMs have been difficult to reconcile with absolute requirements for SM function in vivo.10.7554/eLife.02272.018Figure 9.Working model.(**A**) Subreactions of SNARE-driven fusion. (**i**) Basal fusion, as with SNARE proteoliposomes. (**ii**) SM stimulation of the forward basal fusion reaction. Note that the SM may stimulate *trans*-complex assembly, the fusogenic activity of extant complexes, or both. (**iii**) Disassembly of nascent pre-fusion complexes by Sec17 and Sec18 impairs fusion. (**B**) SM stimulation of fusion in vivo. (**iv**) Sec17 accelerates SM loading onto cognate SNARE complexes, resulting in more efficient fusion and shielding of the complex from premature disassembly by Sec18. The location of the SM on the SNARE--Sec17 complex, and the dissociation of the SM from the post-fusion complex, are speculative. (**v**) The SM does not efficiently bind an improperly assembled, damaged, or non-cognate SNARE complex, exposing the complex to kinetic proofreading by Sec17 and Sec18.**DOI:** [http://dx.doi.org/10.7554/eLife.02272.018](10.7554/eLife.02272.018)

Sec17, Sec18, and ATP completely suppress basal SNARE-mediated liposome fusion ([Figure 9A](#fig9){ref-type="fig"}, reaction iii), likely by binding and prematurely disassembling *trans*-SNARE complexes or their precursors ([@bib67]; [@bib73]; [@bib79]; [@bib88]; but see also; [@bib83]). In these systems the SM, in combination with other factors including HOPS, Munc13, and synaptotagmin, facilitates efficient fusion in the presence of Sec17 and Sec18, suggesting that SMs have a minimum of two fusion-promoting functions. First, SMs promote the assembly of *trans-*SNARE complexes or make them more fusogenic once assembled. Second, SMs protect *trans* complexes from premature disassembly by Sec18 ([Figure 9B](#fig9){ref-type="fig"}, reaction iv). Because multiple cofactors were present in previous studies, it was unclear whether SNARE complex protection from disassembly was attributable directly to SMs, or a property emergent from multiple proteins ([@bib73]; [@bib54]; [@bib88]; [@bib44]). Our experiments now show that SMs functionally interact with the SNARE disassembly machinery in vivo, and affirm that SMs from at least two of the four subfamilies are sufficient to decrease rates of Sec18-mediated SNARE disassembly in vitro. Contrary to expectations, however, Vps33 and Sly1 did not compete with Sec17 for SNARE complex binding. Instead, SNARE-bound Sec17 accelerated SM loading, resulting in the efficient formation of SM--Sec17--SNARE co-complexes with 1:3:1 stoichiometry. Sec17 is therefore a multifunctional SNARE complex adapter, capable of recruiting not only the disassembly ATPase Sec18 but also compartment-specific SMs that oppose Sec18-mediated SNARE disassembly.

SMs, Sec17, and the kinetics of SNARE complex persistence and activity {#s3-2}
----------------------------------------------------------------------

Our results and other converging lines of experimentation suggest a working model in which Sec17 binding to pre-fusion complexes leads to alternative fates ([Figure 9B](#fig9){ref-type="fig"}). When an SM recognizes and binds a Sec17--SNARE complex (reaction iv), it promotes fusion in at least three ways. First, the bound SM directly impedes SNARE disassembly by Sec18. Second, the SM augments the SNARE complex\'s fusogenic activity. Third, by accelerating fusion, the SM shortens the pre-fusion complex\'s lifetime, thereby shortening its temporal exposure to disassembly by Sec18 (kinetic partitioning; [@bib28]). In this view of fusion, SMs function as true enzymes: they bind and stabilize on-pathway intermediates, protect these intermediates from side reactions, and accelerate the conversion of intermediates to end products. Crucially, this model predicts the annihilation of pathway-specific fusion when SMs are deleted from living cells---a result that holds across many different organisms and fusion pathways. When SM function is compromised, pre-fusion SNARE complexes should be less fusogenic, persist for longer times, and be more exposed to premature disassembly by Sec17 and Sec18 ([Figure 9B](#fig9){ref-type="fig"}, reaction v).

A further implication of our working model is that SNAREs, Sec17, SMs, and Sec18 have precisely the features required to implement a kinetic proofreading system ([@bib33]). Kinetic proofreading entails a sequence of independent, driven discrimination events. For SNARE-mediated fusion in vivo, there would be a minimum of two discrimination events. First, the nucleation of the *trans-*SNARE complex (an intermediate analogous to a Michaelis complex) has significant but not absolute intrinsic selectivity, derived mainly from packing interactions at the core of the SNARE bundle. Second, on-pathway SNARE bundles are positively selected by SM proteins. Sec17 detects the general shape and charge distribution of assembled SNARE bundles ([@bib46]), while SMs identify pathway-specific SNARE configurations, protecting them from Sec18 and augmenting their forward fusogenic activity. Error products---off-pathway, incorrectly assembled, or damaged SNARE complexes---would not be efficiently bound by SMs ([Figure 9B](#fig9){ref-type="fig"}, reaction v). These complexes would fuse more slowly or not at all, and would be fully exposed to Sec17 and Sec18-mediated disassembly.

Although SNAREs selectively drive fusion when complexed with cognate partners ([@bib49]), individual SNAREs readily enter into non-cognate, off-pathway, antiparallel or mis-registered complexes with substantial thermal stability and commensurately low off-rates ([@bib8]; [@bib25]). Moreover, certain R-SNAREs (Nyv1, Snc2, Sec22) drive fusion with non-cognate Q-SNAREs ([@bib49]; [@bib35]). Compartment-specific tethers confer additional selectivity by accelerating the forward rate of cognate SNARE pairing, but this may not be sufficient. Normal cellular transactions are replete with opportunities to assemble erroneous SNARE complexes that could drive inappropriate fusion or trigger unregulated and irreversible organelle aggregation. For example, mammalian endosomes progressively associate with endoplasmic reticulum (ER) until 98% of late endosomes and lysosomes are adjacent to ER, generally within 30 nm or less ([@bib24]). Proofreading would emplace a last line of defense against SNARE assembly errors and consequent defects in cell architecture and function.

Additional considerations {#s3-3}
-------------------------

We emphasize that our working schema is necessarily simplified and that pathway-specific specializations are likely to occur. At neuronal synapses, α-SNAP (Sec17) and the Ca^2+^ sensor synaptotagmin compete for SNARE complex binding ([@bib72]). Within this specialized context ([@bib22]; [@bib37]; [@bib75]), synaptotagmin may interact with the SM (Munc18-1) to protect pre-fusion complexes in a manner analogous to Sec17 and Vps33 or Sly1.

The complete sequence of SNARE assembly events during priming, docking, and *trans* complex assembly has not been definitively established for any in vivo pathway. Off-pathway *cis*-SNARE complexes (e.g., Qa~2~-Qb-Qc; [@bib19]; [@bib20]; [@bib45]; [@bib61]), undergo futile cycles of assembly and Sec18/NSF-mediated disassembly, and it has been suggested that SMs might positively select activated pre-docking intermediates ([@bib11]; [@bib12]; [@bib41]; [@bib44]; [@bib25]). In this context it is notable that high levels of Vps33 and Sly1 remain associated with Qa-SNARE domains following complex disassembly by Sec17 and Sec18 ([Figure 3](#fig3){ref-type="fig"}), raising the possibility that SNARE disassembly is coupled to the formation of SM-SNARE subcomplexes prior to docking.

The biochemical experiments in this study were done with complexes in solution, free of membranes. However, the geometry of SNARE juxtamembrane domains in *cis* or *trans*, and especially the geometries of the membrane surfaces before and after fusion, may control whether Sec17 and SMs synergize or compete for binding. Consistent with this idea, Sec17 competes with the HOPS complex for binding to post-fusion *cis*-SNARE complexes on the yeast vacuole, as shown in meticulous co-isolation experiments ([@bib14]). On the other hand, Sec17 interacts cooperatively with poised, partially-zipped *trans*-SNARE complexes on docked vacuoles, triggering fusion ([@bib68]). This Sec17-dependent fusion requires Rab signaling and the HOPS effector complex---including the SM Vps33---but is totally independent of Sec18 and ATP ([@bib68]).

Vps33 and Sly1 binding to core SNARE bundles, with or without Sec17, is slow and rate-limited by temperature ([Figure 8](#fig8){ref-type="fig"}), implying that significant conformational transitions are required for assembly of SM--SNARE complexes. The requirement for physiological (warm) temperatures in our in vitro assays may explain in part why SM--Sec17--SNARE interactions were not previously detected. In vivo, the relevant transitions may occur in a concerted manner; alternatively, they may involve ratchet-like sequential SM association with a series of SNARE assembly intermediates, with each sub-step traversing a smaller energy barrier. The central cavities of SMs are proposed binding sites for SNARE helical bundles and vary in the sizes of their openings, implying conformational flexibility ([@bib5]; [@bib3]; [@bib1]). Our observations provide new empirical support for models in which SM proteins and perhaps SNAREs must undergo substantial conformational transitions to productively associate. The nature of these transitions, and the specific biochemical events that allow SM binding and on-pathway fusion to occur over physiologically relevant time scales, remain to be elucidated.

Materials and methods {#s4}
=====================

Plasmids {#s4-1}
--------

SNAREs and SM open reading frames were cloned into bacterial expresssion vectors using T4 DNA ligase (New England Biolabs, Beverly, MA) as previously described ([@bib43]). In all cases, constructs lacked the SNARE transmembrane domains. In brief, the cytoplasmic domain of Vam3 (aa1-264) was cloned into NcoI/SacI-digested pRSF-1b with no N-terminal tag and C-terminal GST separated from the SNARE by a TEV cleavage site. N-terminal GST tags for the full cytoplasmic domain of Sed5 (aa1-319), or a Sed5~SNARE\ domain~ (aa170-319) construct lacking the N-peptide and Habc domain, were cloned into BamHI/XhoI-cut pGST-Parallel1. The soluble domains of SNAREs were cloned as N-terminal His~6~-tagged fusions into pHIS-Parallel1: Bos1 (aa1-222), Sec22 (aa1-188) were ligated into BamHI/XhoI-cut vector, while Nyv1 (aa1-231) was cloned into NcoI/SacI-digested vector. The SNARE domain of Vam7 (aa190-316) was inserted in-frame into a BamHI/PstI-cut His~6~-GFP-TEV sequence. The soluble domains of Bet1 (aa1-123) and Vti1 (aa1-194) were cloned into BamHI/XhoI-cut or NcoI/PstI-cut (respectively) pRSF-1b carrying an N-terminal His~7~-MBP tag. Full-length Sly1 (aa1-667) was cloned for expression in NcoI/SacI-digested pHIS-Parallel1. Vps33 was cloned for expression in the baculovirus system as described ([@bib7]; [@bib43]). Plasmids overexpressing SNARE disassembly machinery in yeast were made by gap repair recombination of PCR products containing *SEC17* and/or *SEC18*, each with 500 bases of promoter sequence and 300 bases of terminator sequence, into high copy (2µ) vectors pDN526 or pDN524 at unique SacI and HindIII restriction sites, respectively (see [Table 2](#tbl2){ref-type="table"}). We verified overexpression constructs by DNA sequencing and Western blotting of yeast lysates.10.7554/eLife.02272.019Table 2.Yeast lines and plasmids employed in this study**DOI:** [http://dx.doi.org/10.7554/eLife.02272.019](10.7554/eLife.02272.019)NameGenotypeReference or source*S. cerevisiae* SEY6210*MATα leu2-3112 ura3-52 his3-200 trp1-901 lys2-801 suc2-9*[@bib66] WSY41SEY6210; *vps41Δ1::LEU2*[@bib16] BY4742*MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0*ATCC BLY3BY4742; *pep4Δ::KAN VPS33-ttx-GFP::NAT*[@bib43] BLY5BY4742; *pep4Δ::KAN vps33* ^*R281A*^*-ttx-GFP::NAT*[@bib43] BLY6BY4742; *pep4Δ::KAN vps33*^*car*^ ^\[*G297V*\]^*-ttx-GFP::NAT*[@bib43] CBY267S288C; *MATα ade2-1 ura3-1 trp1-1 leu2-3112 can1-100*[@bib90] RSY268 (CBY268)S288C; *MATα ade2-1 ura3-1 trp1-1 leu2-3112 can1-100 sly1*^*ts*^[@bib90]Plasmids pDN526Ap^R^ *2µ URA3*[@bib52] pDN313*SEC18* (pDN526)This study pDN314*SEC17* (pDN526)This study pDN315*SEC17 SEC18* (pDN526)This study pDN524Ap^R^ *2µ TRP1*This study pDN316*SEC18* (pDN524)This study pDN317*SEC17* (pDN524)This study pDN318*SEC17 SEC18* (pDN524)This study pGO735Ap^R^ *CEN LEU2 PGK1pr::RLuc SNA3-FLuc* (pRS415)G Odorizzi (CU-Boulder) pRP1pRSF Km^R^ *His*~*7*~*-MBP-(tev)-*[@bib43] pBL14pBL12 Km^R^ *VAM3 (1-264)-(tev)-GST*[@bib43] pBL19pRP1 Km^R^ *His*~*7*~*-MBP-(tev)-VTI1 (1-194)*[@bib43] pBL20pHIS Parallel1 Ap^R^ *His*~*6*~*-(tev)-NYV1 (1-231)*[@bib43] pBL22pBL12 Km^R^ *His*~*6*~*-GFP*~*A207K*~*-(tev)-Vam7 (190-316)*[@bib43] pBL25pGST Parallel1 Ap^R^ *GST-(tev)-SED5*~*SNARE*~ *(170-319)*This study pBL26pHIS Parallel1 Ap^R^ *His*~*6*~*-(tev)-BOS1 (1-222)*This study pBL27pHIS Parallel1 Ap^R^ *His*~*6*~*-(tev)-SE22 (1-188)*This study pBL49pRP1 Km^R^ *His*~*7*~*-MBP-(tev)-Bet1 (1-123)*This study pBL50pGST Parallel1 Ap^R^ *GST-(tev)-SED5*~*SNARE*~ *(1-319)*This study pBL51pHIS Paralle1 Ap^R^ *His*~*6*~*-(tev)-Sly1*This study pSec17pTYB12 Ap^R^ *CBD-(intein)-Sec17*[@bib68]

Protein expression {#s4-2}
------------------

Vps33 was expressed and purified from insect cells using the *Baculovirus* system as described ([@bib43]). All other proteins were expressed in *E. coli* that harbored a pRIL codon-bias correction plasmid with the exception of Bos1, which was expressed in Rosetta2 pLys cells. Cells were inoculated at 0.05 OD~600~, grown to 1.0--1.2 OD~600~ in Terrific Broth, and expression was induced with 100 µM IPTG for overnight expression at 21°C (His~6~-Sly1, His~6~-Nyv1 and His~7~-MBP-Vti1, GST-Sed5~SNARE\ domain~, His~6~-Bos1, His~7~-MBP-Bet1, His~6~-Sec22), 500 µM IPTG for 4--5 hr at 30°C (His~6~-GFP-Vam7~SNARE~), or 1 mM IPTG for 3 hr at 37°C (Vam3-GST and GST-Sed5).

Protein purification {#s4-3}
--------------------

Cells expressing His-tagged proteins were lysed by sonication in Buffer A (50 mM HEPES, 200 mM NaCl, 10% \[m/v\] glycerol, 5 mM 2-meracptoethanol, 25 mM imidazole, 0.5% TritonX-100, pH 7.4) supplemented with protease inhibitors. Cell lysates were clarified by centrifugation for 25 min at 18,500×*g* at 4°C. The supernatant was incubated with Ni-NTA HP resin (GE Heathcare, Piscataway, NJ) for 10 min at 4°C. The resins were washed extensively in Buffer A followed by washes in Buffer B (20 mM HEPES, 200 mM NaCl, 10% \[m/v\] glycerol, 2 mM 2-mercaptoethanol, 35 mM imidazole, pH 7.4). His-tagged proteins were eluted from the resin with Buffer B supplemented with 400 mM imidazole, and then exchanged into Storage Buffer (20 mM HEPES, 200 mM NaCl, 10% \[m/v\] glycerol, 2 mM 2-mercaptoethanol, pH 7.4) and snap-frozen in liquid nitrogen. Cells containing the GST-tagged SNAREs were lysed in Storage Buffer supplemented with protease inhibitors and 5 mM EDTA, and the clarified lysate was frozen in liquid nitrogen.

Affinity assays {#s4-4}
---------------

SNARE complexes were formed by binding 125 pmol of GST-SNARE (5.8 µg of GST-Sed5~SNARE\ domain~ or 7.1 µg of Vam3-GST) to glutathione sepharose 4B resin (GE Healthcare) for 2 hr at 4°C. Resins were washed twice with SM Assay Buffer: 20 mM HEPES, 150 mM NaCl, 2 mM 2-mercaptoethanol, 0.05% (m/v) Anapoe-X-100 (also called Triton-X-100; Affymetrix, Santa Clara, CA), pH 7.4. A ≥fivefold molar excess of Qb-, Qc-, and R-SNAREs was incubated overnight at 4°C with the GST-SNARE. For vacuole SNARE complexes, these were soluble domains of Vti1 and Nyv1 and the SNARE domain of Vam7: His~7~-MBP-Vti1, His~6~-GFP-Vam7~SNARE~, and His~6~-Nyv1. For Golgi SNARE complexes, these were soluble domains of Bos1, Bet1, and Sec22: His~6~-Bos1, His~7~-MBP-Bet1, His~6~-Sec22. Unbound SNAREs were removed from SNARE complexes by washing the resins with SM assay buffer twice at 4°C and twice at room temperature. Sec17, the SM protein, or both were added at the indicated concentration to binding reactions containing immobilized SNARE complex (500 nM final, unless otherwise specified). Pulldowns were performed at 30°C for 1 hr, the resins were washed three times, and eluted with SM Assay Buffer supplemented with 20 mM reduced glutathione, pH 7.4. Samples were boiled in SDS-loading buffer, and separated using 12% SDS-PAGE for experiments using Sly1 or 10% SDS-PAGE for experiments using Vps33.

SDS-PAGE imaging and quantification {#s4-5}
-----------------------------------

Unless otherwise indicated, all gels shown were stained with Coomassie brilliant blue and imaged on an Epson 4490 transmission scanner. All experiments were repeated three times or more; representative gels are shown. Quantification of protein binding was performed using SYPRO-Ruby stain (Invitrogen, Carlsbad, CA) and a standard curve of each relevant protein, and gels were imaged using a Gel Doc XR+ (Bio-Rad, Hercules, CA). Where indicated, experiments with Vps33 were done twice rather than 3 or more times due to limitations in the amount of available protein. Data from three experiments (Sly1) or two experiments (Vps33) were plotted as fractional saturation of SM protein binding to immobilized SNARE complex, relative the total concentration of free SM protein in solution. Kd~obs~ values and Hill coefficients were estimated by nonlinear fitting (GraphPad Prism v. 5) of a single-site binding model with Hill coefficient to the data. Two-site models did not substantially improve the quality of the fits. Thermal coefficients (Q~10~) of SM association with SNARE or Sec17-SNARE complexes were calculated as$$\text{Q}_{10} = \left( {\text{X}_{2}/\text{X}_{1}} \right)^{10/{({\text{T}2 - \text{T}1})}}$$where X~1~ and X~2~ are the binding efficiencies at lower and higher temperatures, T~1~ and T~2~ ([@bib32]). The Q~10~ values were extrapolated from the slope of the steepest part of the temperature-binding curve.

SNARE disassembly and re-assembly {#s4-6}
---------------------------------

Sec18 activity was assayed in SNARE Disassembly Buffer, which was SM Assay Buffer with 1 mM ATP and 2 mM MgCl~2~, pH 7.4. Unless otherwise noted, the SM protein and Sec17 were allowed to bind to SNARE complexes for 1 hr at 30°C before addition of Sec18. Disassembly reactions were then incubated for the indicated times and quenched by washing the samples in ice-cold SM Assay Buffer with 10 mM EDTA final, pH 7.4. Remaining resin-bound proteins were eluted with SM Assay Buffer containing 20 mM reduced glutathione, pH 7.4 at room temperature. To assay re-assembly of SNARE complexes, SNARE complexes were disassembled for 30 min at 30°C. Sec18 activity was then quenched with a final concentration of 10 mM EDTA, reactions were supplemented with additional soluble Qb, Qc, and R-SNAREs as indicated, and incubated at 30°C for 30 min.

Cell growth and trafficking {#s4-7}
---------------------------

Limiting plate dilutions were performed by growing yeast carrying plasmid vectors overnight at permissive temperature in synthetic media lacking Ura and with 2% (m/v) glucose and 0.05% (m/v) casamino acids. OD~600~ was measured for each culture to permit equalization of cell mass. Cells were serially diluted onto synthetic media dropout plates. Growth curves in liquid were obtained as described ([@bib57]) but used synthetic media lacking Ura and with 2% glucose and 0.05% casamino acids. To prevent cell clumping in the Bioscreen-C machine (Growth Curves USA), 0.2% Nonidet-P40 was added to synthetic media ([@bib48]). For studies of Zn^2+^ sensitivity, synthetic medium was prepared with asparagine at molar equivalence to, and in place of, the usual ammonium and adjusted to pH 6.5. This allowed 1 mM ZnCl~2~ to remain soluble. YODA software ([@bib55]) was used to analyze growth curve data. Cargo protein sorting was assayed using LUCID ([@bib52]).
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "SM proteins Sly1 and Vps33 co-assemble with Sec17 and SNARE complexes to oppose SNARE disassembly by Sec18" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor and 3 reviewers, one of whom is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewers discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

All reviewers found your work interesting and recommended publication after appropriate revision. In particular, simultaneous binding of Sec17 and an SM protein to a SNARE complex is unprecedented and unexpected. By altering our fundamental understanding of how the key components of the membrane fusion machinery interact, this discovery seems likely to have a major impact on future work in the field.

There were several technical concerns and questions for clarification. Of these, there is one all reviewers would like you to address:

The findings from Carpp et al. (JCB 2006) that a point mutation in Vps45 can shift the equilibrium binding between a Tlg2 SNARE-binding mode to a SNARE complex-binding mode is consistent with the idea presented here that increasing the temperature increases the probability that the SM protein can shift into a SNARE complex-binding mode. Hence, the increased rate of binding at higher temperatures. Perhaps pre-heating the SM protein alone first would increase the rate of binding when subsequently added to Sec17-SNARE complexes (or SNARE complexes alone), this could indicate that the conformational change is restricted to the SM protein only. Other issues to address -- note that we do not consider it as essential to carry out additional experiments to address them -- they are for your consideration and/or editorial changes.

*Reviewer* *\#1:*

1\) While the evidence for SM-Sec17-SNARE complexes seems overwhelming, I was not entirely convinced that assembly of this \'ternary\' complex is "highly cooperative" Establishing cooperativity would seem to require additional evidence or, if I am missing something, at least a more careful marshalling of the existing evidence.

2\) I can see why the authors favor the model that the SM protein binds to a composite surface that includes both Sec17 and the SNARE bundle. Nonetheless, I don\'t think that an alternative model can really be ruled out in which the SM protein recognizes a distinct configuration of Sec17 molecules achieved only when they are bound to the \'cognate\' SNARE complex.

3\) In relation to [Figure 3](#fig3){ref-type="fig"}, it\'s important to mention that syntaxin 5 lacks the N-terminal peptide. This becomes a major point later. Possibly, to avoid complicating the narrative, it would be OK to mention this only in the legend of [Figure 3](#fig3){ref-type="fig"}.

4\) "The Sec17 concentration required to saturate Golgi SNARE complex was about four-fold greater than for vacuole SNARE complex." Are these data not shown?

*Reviewer* *\#2:*

1\) In contrast to the findings shown here, Togneri et al (PNAS 2006), demonstrated that (at least under the conditions tested) the yeast SM protein Sec1 was unable to prevent disassembly of the exocytic SNARE complexes by Sec17/18. This should be discussed; is it possible that Sec1 is sufficiently different from Sly1 and Vps33?

2\) Along those lines, a more "universal" picture would be gained by demonstrating that other SM proteins also show these conserved features. Vps45 and Sec1 could be tested, to complete the yeast family, and/or Munc18-1 or Munc18c. This may be beyond the scope of this manuscript.

3\) It is not clear, given the SNAP-SNARE complex binding data and model from Marz et al. (JBC 2003), and a variety of SM mutants with disrupted binding to SNARE complexes, how to build a model for the SM and 3 copies of Sec17 binding to SNARE complexes at the same time. There does not seem to be enough room available.

4\) "\...but Sec17 does not bind either Sly1 or Sed5 in the absence of the assembled SNARE complex." This is misleading, because [Figure 6F](#fig6){ref-type="fig"} actually shows that Sec17 can bind Sly1, IF Sly1 is not bound to full-length Sed5 ([Figure 6B](#fig6){ref-type="fig"}, not 6C). This is a curious finding that might indicate that binding of the N-peptide of Sed5 may affect the conformation of Sly1 (as suggested in Furgason et al (PNAS 2009) for Vps45-Tlg2 binding. In the cell, the syntaxin-family SNAREs will have their N-terminal domains and N-peptides, how does this affect the proposed model?

5\) Use of the word "universal", especially "universal co-chaperone" and "universal disassembly engine". Although many of us would appreciate the membrane trafficking centric view of biology, this terminology, it is quite confusing due to many other co-chaperones and disassembly machine for other non-membrane trafficking biological processes.

6\) The Q10 thermal coefficient needs to be better defined, referenced and the calculations described in M&M

7\) In the figures, the axis need to be consistently clear whether the protein being tested is full-length Sec5 or the SNARE domain only (the labels change from panel to panel).

8\) In [Figures 3B and 3C](#fig3){ref-type="fig"}, it is curious that the SM stays bound to the SNARE complexes after disassembly by Sec18/Sec17, while Sec17 is removed. It is not clear how this fits into the overall picture of SM-Sec17 function proposed here.

9\) Not necessary to provide the genotype for commercially available E. coli strains.

10\) The plasmid information in [Table II](#tbl2){ref-type="table"} is rather limited and the relevant information is not obvious from the Materials and methods

*Reviewer* *\#3:*

1\) The problem is that conclusions are drawn about pre-fusion complexes but all biochemical experiments are carried out with fully assembled SNARE complexes that represent the post-fusion state. To me it is unclear why SM proteins should block disassembly of a "cis" SNARE complex such as the one immobilized on the beads - biologically this does not make much sense. It needs to be explained how the SM proteins (or NSF) differentiate between prefusion and postfusion complexes (apparently the authors are aware of the problem -- see question mark on the right in [Figure 9B](#fig9){ref-type="fig"}, pathway IV). Thus the cartoon does not represent the findings correctly as all experiments were done with SNARE complexes shown on the far right in the cartoon (after fusion). Answering this question would require different approaches and is probably not straightforward.

2\) I have some concerns about the fact that all experiments are carried out on beads under equilibrium conditions, i.e., using long incubation times, with the Q-a SNARE being immobilized. For instance, it is unclear to me why such long preincubation is required for the SM-proteins to exert their inhibitory effect on Sec18p-driven disassembly -- as far as I remember previous work binding is fast. Similarly, I consider it as problematic to carry out re-assembly kinetics in such a manner -- the bands are barely visible ([Figure 4C](#fig4){ref-type="fig"}) and only become convincing after adding an approx. 6fold excess of soluble SNAREs, and kinetic resolution is poor. Furthermore, it is conceivable that binding of SM-proteins to a preassembled complex including SNAREs and alpha-SNAP may nonspecifically prevent access of the bulky Sec18p protein (that may not be able anymore to enter the pores of the resin) rather than blocking access to the SNARE complex. For these reasons I suggest to carry out at least one or two control experiments in solution or with the Qa-SNARE being incorporated into the membrane of liposomes.

10.7554/eLife.02272.021

Author response

*The findings from Carpp et al. (JCB 2006) that a point mutation in Vps45 can shift the equilibrium binding between a Tlg2 SNARE-binding mode to a SNARE complex-binding mode is consistent with the idea presented here that increasing the temperature increases the probability that the SM protein can shift into a SNARE complex-binding mode. Hence, the increased rate of binding at higher temperatures. Perhaps pre-heating the SM protein alone first would increase the rate of binding when subsequently added to Sec17-SNARE complexes (or SNARE complexes alone), this could indicate that the conformational change is restricted to the SM protein only*.

This is an important question. We performed the suggested experiment (now included as [Figure 8--figure supplement 2](#fig8s2){ref-type="fig"}). The results show that pre-incubation of Sly1 at 30° C versus lower temperatures has no effect on the subsequent efficiency of Sly1 binding to the SNARE-Sec17 complex. This indicates that elevated temperature does not induce a time-stable binding competence to Sly1 or the other proteins in the system, and is consistent with the interpretation that binding requires Sly1 or perhaps another molecule in the system to equilibrate between two states: a sparsely-occupied (higher-energy), binding-competent state, and a densely-occupied (lower-energy), binding incompetent state. Elevated temperature would increase the rate of inter-conversion between these states, elevating the rate of productive complex formation.

Reviewer \#1:

*1) While the evidence for SM-Sec17-SNARE complexes seems overwhelming, I was not entirely convinced that assembly of this \'ternary\' complex is "highly cooperative" Establishing cooperativity would seem to require additional evidence or, if I am missing something, at least a more careful marshalling of the existing evidence*.

The relevant distinction may be semantic, but that does not mean it is unimportant. There are multiple types of cooperativity, among which one may delineate at least two classical cases (Ptashne, 2007). The first case is positive conformational cooperativity (allostery), exemplified by the affinity increase that occurs as molecules of O2 sequentially bind hemoglobin. The second case is simpler and more general: the combined effect of multiple binding sites (avidity). It is exemplified by binding of monomeric phage λ repressor to its individual DNA operator half-site, versus the considerably stronger binding of λ repressor to its native palindromic operator, resulting from a low-affinity dimerization interface on the repressor protein. This type of cooperativity can in principle occur solely through rigid body interactions, or it can be coupled to conformational dynamics. Although we do not yet have a deep mechanistic understanding of how SM-Sec17-SNARE assembly occurs, the present experiments strongly support this more general kind of cooperative assembly. We removed the word "highly" to more precisely convey what can, and cannot yet, be said about the mechanisms that drive this assembly reaction.

*2) I can see why the authors favor the model that the SM protein binds to a composite surface that includes both Sec17 and the SNARE bundle. Nonetheless, I don\'t think that an alternative model can really be ruled out in which the SM protein recognizes a distinct configuration of Sec17 molecules achieved only when they are bound to the \'cognate\' SNARE complex*.

For an SM to exhibit selectivity for its cognate SNARE-Sec17 complex without direct SM-SNARE contacts, Sec17 would need to bind each SNARE complex in a distinct conformation, and these conformational differences would then need to be transmitted to, and recognized by, the SM. This is far from the simplest explanation of our results but it cannot at present be excluded. We note that Vps33 has the intrinsic ability to recognize cognate versus non-cognate SNARE complexes. That is, Sec17-dependent and Sec17-independent binding of Vps33 to SNARE complex are of different affinities, but exhibit comparable selectivity ([Figure 7A](#fig7){ref-type="fig"}, compare Vps33 binding in lanes 2 and 2´; see also [@bib43]. We have modified the Results to emphasize the selectivity of this recognition rather than its underlying mechanism.

*3) In relation to* [*Figure 3*](#fig3){ref-type="fig"}*, it\'s important to mention that syntaxin 5 lacks the N-terminal peptide. This becomes a major point later. Possibly, to avoid complicating the narrative, it would be OK to mention this only in the legend of* [*Figure 3*](#fig3){ref-type="fig"}.

We agree and have made the suggested changes. We emphasize that in the SNARE disassembly assays, comparable results were obtained with SNARE complexes built on the Sed5 SNARE domain ([Figure 3](#fig3){ref-type="fig"}), or with complexes built on the full Sed5 cytoplasmic domain ([Figure 3--figure supplement 3](#fig3s3){ref-type="fig"}).

*4) "The Sec17 concentration required to saturate Golgi SNARE complex was about four-fold greater than for vacuole SNARE complex." Are these data not shown*?

The divergent Sec17 affinity for different SNARE complexes was initially noted in binding optimization studies that are not shown. However, the difference is evident in experiments that are shown, as now noted in Results. Compare the amount of Sec17 required to saturate vacuole SNARE complex (5 µM; [Figure 5B](#fig5){ref-type="fig"}) vs. Golgi SNARE complex (20 µM; [Figure 6B](#fig6){ref-type="fig"}). The reported dissociation constant (half-maximal saturation) of α-SNAP for neuronal SNARE complexes in solution is ∼5 µM ([@bib46]; Winter et al., 2009).

Reviewer \#2:

*1) In contrast to the findings shown here, Togneri et al (PNAS 2006), demonstrated that (at least under the conditions tested) the yeast SM protein Sec1 was unable to prevent disassembly of the exocytic SNARE complexes by Sec17/18. This should be discussed; is it possible that Sec1* *is sufficiently different from Sly1 and Vps33?*

The referee is correct. Indeed, like Togneri et al. for Sec1, [@bib58], reported that Sly1 does not prevent NSF-mediated SNARE disassembly. However, in these studies only endpoints and not intermediate stages of disassembly were examined. In the present experiments disassembly also ran to completion, but in the presence of bound Vps33 or Sly, we observed kinetic delays (vs. absolute blockades of disassembly) at intermediate time points.

*2) Along those lines, a more "universal" picture would be gained by demonstrating that other SM proteins also show these conserved features. Vps45 and Sec1 could be tested, to complete the yeast family, and/or Munc18-1 or Munc18c. This may be beyond the scope of this manuscript*.

Agreed. We see the comparative analysis of Vps33 and Sly1 as a strength of the present experiments, and anticipate that the results will spur additional experimentation from other scientists working on SM proteins.

*3) It is not clear, given the SNAP-SNARE complex binding data and model from Marz et al. (JBC 2003), and a variety of SM mutants with disrupted binding to SNARE complexes, how to build a model for the SM and 3 copies of Sec17 binding to SNARE complexes at the same time. There does not seem to be enough room available*.

This is a major question, particularly at the synapse where Munc-13, Munc-18, synaptotagmin, complexin, and perhaps other factors all appear to engage the pre-fusion trans-SNARE complex. At present, the most plausible model for how an SM might engage the tetrahelical SNARE bundle is derived from the crystal structure of Munc-18/nSec1 bound to the closed form of syntaxin, which folds into a tetrahelical bundle that might be a structurally analogous to the SNARE complex (Misura et al., 2000).Author response image 1.

If this structural analogy is broadly correct, well over half of the SNARE bundle circumference, and most of the bundle's surface area, should be exposed for Sec17/α-SNAP binding. In a recent single-particle EM study of 20S SNARE- α-SNAP-NSF complexes (Chang et al., 2012), C3 (threefold rotational) symmetry was imposed for SNARE-bound Sec17, resulting in a C4:C3 SNARE--α-SNAP pseudosymmetry mismatch. To the best of our knowledge there is no experimental basis for this imposition of C3 symmetry. In an alternative model, Hanson's group proposed that three adjacent Sec17/α-SNAP molecules wrap around one side of the SNARE complex ([@bib46]) -- an arrangement that could readily accommodate three Sec17/α-SNAP molecules and one SM per SNARE bundle, as observed in our experiments.

*4) "\...but Sec17 does not bind either Sly1 or Sed5 in the absence of the assembled SNARE complex." This is misleading, because* [*Figure 6F*](#fig6){ref-type="fig"} *actually shows that Sec17 can bind Sly1, IF Sly1 is not bound to full-length Sed5 (*[*Figure 6B*](#fig6){ref-type="fig"}*, not 6C). This is a curious finding that might indicate that binding of the N-peptide of Sed5 may affect the conformation of Sly1 (as suggested in Furgason et al (PNAS 2009) for Vps45-Tlg2 binding. In the cell, the syntaxin-family SNAREs will have their N-terminal domains and N-peptides, how does this* *affect the proposed model?*

There are a few issues to discuss here. First, the interaction between the Sly1 and the N-peptide of Sed5 is not required for fusion ([@bib59]). Vps33 does not have an N-peptide binding pocket and does not interact with the N-peptide of Vam3. Moreover, Vam3 does not enter into a closed conformation and the N-terminal domains of Vam3 are nonessential for Vam3 function (Dulubova et al., 2001; [@bib43]; [@bib1]; Wang et al., 2001; Laage and Ungermann, 2001). Similarly, yeast Sec1 does not interact with Qa-SNARE N-peptide ([@bib77]). Thus, interactions between SM proteins and Qa-SNARE N-peptides are not universal and, where they do occur, they are not consistently important for SM function. If there is indeed a general function of SM proteins in SNARE-mediated fusion, that function cannot generally depend on Qa-SNARE N-peptide interactions. Nevertheless, it is still possible that Sed5 N-peptide binding to Sly1 initiates a conformational change that regulates Sly1 assembly dynamics, as suggested for Vps45 and for mammalian Sly1 (Furgason et al., 2009; Arac et al., 2005).

[Figure 6F](#fig6){ref-type="fig"} may indeed indicate some affinity between Sly1 and Sec17. However, the main conclusion of this experiment is that Sly1 does not readily bind the SNARE core bundle unless Sec17 is present. Because this experiment was analyzed by immunoblot, we caution that additional control experiments would be required before we could definitively conclude that the Sec17 signal observed in the absence of SNARE complex ([Figure 6F](#fig6){ref-type="fig"}, lane 2) is specific binding rather than background. This is particularly so given the result of [Figure 6B](#fig6){ref-type="fig"} (lanes 7 and 8), where Sec17 binding to Sed5-tethered Sly1 is not detected. We have modified the relevant passage in the Results to clarify the nature of this uncertainty.

*5) Use of the word "universal", especially "universal co-chaperone" and "universal disassembly engine". Although many of us would appreciate the membrane trafficking centric view of biology, this terminology, it is quite confusing due to many other co-chaperones and disassembly machine for other non-membrane trafficking biological processes*.

We\'ve deleted the word "universal," and taken some care to specify that Sec17 and Sec18 are general SNARE disassembly factors rather than universal protein chaperones.

6\) The Q10 thermal coefficient needs to be better defined, referenced and the calculations described in M&M

Estimation of Q10 is now described in the Methods, and a reference to classical applications is cited (Hille, 1991, p. 51 ff).

*7) In the figures, the axis need to be consistently clear whether the protein being tested is full-length Sec5 or the SNARE domain only (the labels* *change from panel to panel)*

Done.

*8) In* [*Figures 3B and 3C*](#fig3){ref-type="fig"}*, it is curious that the SM stays bound to the SNARE complexes after disassembly by Sec18/Sec17, while Sec17 is removed. It is not clear how this fits into the overall picture of SM-Sec17 function proposed here*.

We agree. Additional in vitro and in vivo experimentation will be needed to evaluate the significance of this observation.

*9) Not necessary to provide the genotype for commercially available E. coli strains*.

OK.

*10) The plasmid information in* [*Table II*](#tbl2){ref-type="table"} *is rather limited and the relevant information is not obvious from the Materials and methods*

We have more clearly described how the plasmids were constructed.

Reviewer \#3:

*1) The problem is that conclusions are drawn about pre-fusion complexes but all biochemical experiments are carried out with fully assembled SNARE complexes that represent the post-fusion state. To me it is unclear why SM proteins should block disassembly of a "cis" SNARE complex such as the one immobilized on the beads -- biologically this does not make much sense. It needs to be explained how the SM proteins (or NSF) differentiate between prefusion and postfusion complexes (apparently the authors are aware of the problem -- see question mark on the right in* [*Figure 9B*](#fig9){ref-type="fig"}*, pathway IV). Thus the cartoon does not represent the findings correctly as all experiments were done with SNARE complexes shown on the far right in the cartoon (after fusion). Answering this question would require different approaches and is probably not straightforward*.

There are two critical differences between pre-fusion trans-SNARE complexes and post-fusion cis-SNARE complexes: first, differences in the conformations of the C-terminal (juxtamembrane) segments of the proteins; and second, differences in the topology and topography of the membranes within which the SNAREs are anchored. With only cytoplasmic domains (but not transmembrane segments and the associated membranes), it is inappropriate to identify the complexes studied here as either cis or trans.

In previous work we demonstrated that authentic kinetically stable trans-SNARE complexes assembled through the native docking pathway can be trapped on intact vacuolar lysosomes. These trans-complexes are zipped to packing layer +3 or +4; we and others have presented strong evidence that Sec17 can functionally and physically interact with these trapped trans-complexes ([@bib68]; [@bib88]). Moreover, single-molecule laser tweezers experiments with neuronal SNARE complexes are fully consistent with the interpretation that pre-fusion complexes zipper to layer +3 or +4 (Gao et al., 2012). Thus, ∼70% of the SNARE bundle can be fully folded in the pre-fusion trans-complex.

The SM binding footprint on the SNARE bundle has not been mapped in detail for any SM. Consequently, it is still unclear whether Sec17, SMs, or both operating in concert, can discriminate in functionally meaningful ways between cis- and trans-SNARE complexes. However, we emphasize that functional experimentation with liposomes initially prompted the hypothesis that SM proteins protect trans-SNARE complexes from premature disassembly ([@bib44]; Mima and Wickner, 2009; [@bib50]; [@bib88]). Our preferred working model focuses on SM and Sec17 association with pre- versus post-fusion complexes, because that interpretation is most consistent not only with the present in vivo and biochemical experiments, but with functional studies published by other laboratories. If our working model inspires experiments that cause it to be supplanted by a better model, it will have served its purpose.

*2) I have some concerns about the fact that all experiments are carried out on beads under equilibrium conditions, i.e., using long incubation times, with the Q-a SNARE being immobilized. For instance, it is unclear to me why such long preincubation is required for the SM-proteins to exert their inhibitory effect on Sec18p-driven disassembly -- as far as I remember previous work binding is fast*.

To our knowledge, no one has previously reported Sly1 binding directly to the SNARE core bundle. In previous work, SNARE complexes were assembled on the full cytoplasmic domain of Sed5 -- including the Sed5 N-peptide, which Sly1 binds with low-nM affinity. Because the on-rate for this high-affinity binding interaction is fast ([Figure 8e](#fig8){ref-type="fig"}), the slower on-rate of Sly1 binding to the SNARE core bundle would have been obscured by the high-affinity Sly1-N-peptide interaction in previously published experiments. The slow on-rate of Sly1 (and of Vps33) binding to SNARE core bundles could reflect a requirement for another protein or a small molecule that accelerates binding, or it could reflect the initial recruitment of the SM to a SNARE assembly intermediate. These issues were raised at length in the original Discussion. In the current submission, the text has been modified for greater clarity.

*Similarly, I consider it as problematic to carry out re-assembly kinetics in such a manner -- the bands are barely visible (*[*Figure 4C*](#fig4){ref-type="fig"}*) and only become convincing after adding an approx. 6fold excess of soluble SNAREs, and kinetic resolution is poor*.

The experiments in [Figure 4C](#fig4){ref-type="fig"} are controls, and are set up specifically not to show assembly end-points, but rather to ascertain whether the increased abundance of SNARE complexes following disassembly in the presence of Vps33 or Sly1 ([Figure 3](#fig3){ref-type="fig"}) reflect increases in re-assembly. The experiment was run under the conditions of [Figure 3](#fig3){ref-type="fig"} specifically to control for that possibility. We reiterate that experiments showing that Sly1 and Vps33 do not stimulate SNARE assembly in solution have also been reported by other laboratories ([@bib31]; [@bib39]; [@bib58]).

*Furthermore, it is conceivable that binding of SM-proteins to a preassembled complex including SNAREs and alpha-SNAP may nonspecifically prevent access of the bulky Sec18p protein (that may not be able anymore to enter the pores of the resin) rather than blocking access to the SNARE complex. For these reasons I suggest to carry out at least one or two control experiments in solution or with the Qa-SNARE being incorporated into the membrane of liposomes*.

The relatively low density of SNARE complex on the affinity resin, and the complete disassembly we observe, suggests that steric occlusion is not a major issue. Moreover, the multiple-turnover rate we observe for Sec18-mediated disassembly of Golgi SNARE complexes (1.35±0.01 complexes • Sec18 hexamer-1 • min-1; [Figure 3--figure supplement 2](#fig3s2){ref-type="fig"}) are identical to the rate observed in solution for NSF-mediated disassembly of neuronal complexes under similar ionic conditions (∼1 complex • Sec18 hexamer-1 • min-1; [@bib13]). Moreover, the rate of disassembly in our assays is linear over the time intervals assayed, further indicating that there is not a less-accessible subpopulation of complexes buried within the affinity matrix.

[^1]: The Q/R taxonomy of SNARE domain subfamilies is derived from [@bib22].
